RNA sequencing of cancer reveals novel splicing alterations

Jeyanthy Eswaran1, Anelia Horvath, Sucheta Godbole

  • 1McCormick Genomic and Proteomics Center, The George Washington University, Washington, District of Columbia 20037, USA.

Scientific Reports
|April 23, 2013
PubMed

Insights

This study reveals unique splicing patterns in triple-negative, non-triple-negative, and HER2-positive breast cancers. Researchers identified novel transcripts and splicing events critical for understanding breast cancer subtypes.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Splicing is crucial for generating functional transcripts in cells.
  • Breast cancer involves complex regulatory changes in gene expression.

Purpose of the Study:

  • To systematically analyze splicing signatures across major breast cancer subtypes.
  • To identify novel subtype-specific splice variants and deregulated transcriptional events.

Main Methods:

  • RNA sequencing was employed to analyze transcriptomes of triple-negative (TNBC), non-TNBC, and HER2-positive breast cancers.
  • Differential splicing analysis was performed to identify subtype-specific events.

Main Results:

  • Subtype-specific differentially spliced genes and novel splice isoforms were discovered.
  • Exon skipping and intron retention were identified as predominant splicing events.
  • Differential primary transcript expression and promoter switching were significantly deregulated in breast cancer.
  • Novel hybrid isoforms of key molecules (e.g., CDK4, LARP1) were validated.

Conclusions:

  • This research provides a comprehensive view of transcriptional and splicing signatures specific to breast cancer subtypes.
  • The identification of previously unknown transcripts highlights the need for updated transcriptome annotation in breast cancer.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...